Use of Surface Electromyography Biofeedback to Improve Reaching in Children With Cerebral Palsy

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2007 by Stanford University.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by:
Stanford University
ClinicalTrials.gov Identifier:
NCT00473161
First received: May 11, 2007
Last updated: NA
Last verified: May 2007
History: No changes posted
  Purpose

A newly-developed device for biofeedback of surface EMG will be used to either increase or decrease activity in the muscles of children with poor reaching due to cerebral palsy.


Condition Intervention Phase
Cerebral Palsy
Weakness
Hypertonia
Device: surface EMG biofeedback
Phase 1
Phase 2

Study Type: Observational
Study Design: Observational Model: Defined Population
Primary Purpose: Screening
Time Perspective: Cross-Sectional

Resource links provided by NLM:


Further study details as provided by Stanford University:

Estimated Enrollment: 20
Study Start Date: May 2007
Detailed Description:

Children ages newborn to 21 with a diagnosis of arm weakness, hypertonia, or hyperkinesia due to cerebral palsy will be recruited. A muscle that is either over-active or under-active will be selected for each child. The child will be provided with the device to wear for 1 month in order to call attention to the identified muscle. At the beginning and end of the month, reaching will be assessed using three-dimensional kinematic motion capture. The outcome measure will be the speed and curvature of reaching to a target in front of the child.

  Eligibility

Ages Eligible for Study:   1 Month to 21 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • weakness, hypertonia, or hyperkinetic disorder affecting one or both arms
  • reduced speed or quality of reaching

Exclusion Criteria:

  • any condition that would increase the risk of participation
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00473161

Contacts
Contact: Terence D Sanger, MD, PhD 650-736-2154 sanger@stanford.edu

Locations
United States, California
Stanford University Not yet recruiting
Stanford, California, United States, 94305
Principal Investigator: Terence D Sanger, PhD         
Sponsors and Collaborators
Stanford University
Investigators
Principal Investigator: Terence D Sanger, MD PhD Stanford University
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00473161     History of Changes
Other Study ID Numbers: EMG biofeedback
Study First Received: May 11, 2007
Last Updated: May 11, 2007
Health Authority: United States: Institutional Review Board

Keywords provided by Stanford University:
movement disorders
childhood

Additional relevant MeSH terms:
Asthenia
Cerebral Palsy
Muscle Hypertonia
Signs and Symptoms
Brain Damage, Chronic
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Neuromuscular Manifestations
Neurologic Manifestations

ClinicalTrials.gov processed this record on April 16, 2014